Glycemic Index and Chronic Disease Risk (Mostly in Women)

"Would you like some high-glycemic index bread?"

"Would you like some high-glycemic index bread?"

I recently blogged about glycemic index (GI), glycemic load (GL), and glycemic diets in preparation for today’s post.

The concept of glycemic index was introduced by Jenkins et al in 1981 at the University of Toronto.

Studies investigating the association between disease risk and GI/GL have been inconsistent.  By “inconsistent,” I mean some studies have made an association in one direction or the other, and other studies have not.  Diseases possibly associated with high-glycemic diets have included diabetes, cardiovascular disease, cancer, gallbladder disease, and eye disease.

“Diet” in this post refers to a habitual way of eating, not a weight loss program.

Researchers with the University of Sydney (Sydney, Australia) identified the best-designed published research reports investigating the relationship between certain chronic diseases and glycemic index and load.  The studied diseases were type 2 diabetes, coronary heart disease, stroke, breast cancer, colorectal cancer, pancreatic cancer, endometrial cancer, ovarian cancer, gallbladder disease, and eye disease.

Methodology

Literature databases were searched for articles published between 1981 and March, 2007.  The researchers found 37 studies that enrolled 1,950,198 participants ranging in age from 24 to 76, with BMI’s averaging 23.5 to 29.  These were human prospective cohort studies with a final outcome being occurrence of a chronic disease (not its risk factors).  Twenty-five of the studies were conducted in the U.S., five in Canada, five Europe, and two in Australia.  Ninety percent of participants were women [for reasons not discussed].  Food frequency questionnaires were used in nearly all the studies.  Individual studies generated between 4 to 20 years of follow-up, and 40,129 new cases of target diseases were identified.

Associations between GI, GL, and risk of developing a chronic disease were measured as rate ratios comparing the highest with the lowest quantiles.  For example, GI and GL were measured in the study population.  The population was then divided into four groups (quartiles), reflecting lowest GI/GL to medium to highest GI/GL diets.  The lowest GI/GL quartile was compared with the highest quartile to see if disease occurrence was different between the groups.  Some studies broke the populations into tertiles, quintiles, deciles, etc.

Findings

Comparing the highest with the lowest quantiles, studies with a high GI or GL independently

  • increased the risk of type 2 diabetes by 27 (GL) or 40% (GI)
  • increased the risk of coronary heart disease by 25% (GI)
  • increased the risk of gallbladder disease by 26% (GI) or 41% (GL) [gallstones and biliary colic, I assume, but the authors don’t specify]
  • increased the risk of breast cancer by 8% (GI)
  • increased risk of all studied diseases (11) combined by 14% (GI) or 9% (GL)

Overall, high GI was more strongly associated with chronic disease than was high GL
So low-GI diets may offer greater protection against disease than low-GL diets.

Comments from the Researchers

They speculate that low-GI diets may be more protective than low-GL because the latter can include low-carb foods such as cheese and meat, and low-GI, high-carb foods.  Both eating styles will reduce glucose levels after meals while having very different effects in other areas such as pancreas beta cell function, free fatty acid levels, triglyceride levels, and effects on satiety.

High GI and high GL diets, independently of known confounders, modestly increase the risk of chronic lifestyle-related diseases, with more pronounced effects for type 2 diabetes, coronary heart disease, and gallbladder disease.

Direct quotes:

. . . 90% of participants were female; therefore, the findings may not be generalizable to men.

There are plausible mechanism linking the development of certain chronic diseases with high-GI diets.  Specifically, 2 major pathways have been proposed to explain the association with type 2 diabetes risk.  First the same amount of carbohydrate from high-GI food produces higher blood glucose concentrations and a greater demand for insulin.  The chronically increased insulin demand may eventually result in pancreatic beta cell failure, and, as a consequence, impaired glucose tolerance.  Second, there is evidence that high-GI diets may directly increase insulin resistance through their effect on glycemia, free fatty acids, and counter-regulatory hormone secretion.  High glucose and insulin concentrations are associated with increased risk profiles for cardiovascular disease, including decreased concentrations of HDL cholesterol, increased glycosylated protein, oxidative status, hemostatic variables, and poor endothelial function

Low-GI and/or low-GL diets are independently associated with a reduced risk of certain chronic diseases.  In diabetes and heart disease, the protection is comparable with that seen for whole grain and high fiber intakes.  The findings support the hypothesis that higher postprandial glycemia is a universal mechanism for disease progression.

My Comments

Studies like this tend to accentuate the differences in eating styles since they compare the highest with the lowest post-prandial (after meal) glucose levels.  Most people are closer to the middle of the pack, so a person there has potentially less to gain by moving to a low-GI diet.  But still some to gain, on average, particularly in regards to avoiding type 2 diabetes and coronary heart disease.

[To be fair, many population-based studies use this same quantile technique.  It increases the odds of finding a statistically significant difference.]

Only two of the 37 studies examined coronary heart disease, the cause of heart attacks.  One study was the massive Nurses’ Health Study database with 75,521 women.  The other was the Zutphen (Netherlands) Elderly Study which examined men 64 and older.  Here’s the primary conclusion of the Zutphen authors verbatim:

Our findings do not support the hypothesis that a high-glycemic index diet unfavorably affects metabolic risk factors or increases risk for CHD [coronary heart disease] in elderly men without a history of diabetes or CHD.

So there’s nothing in the meta-analysis at hand to suggest that high-GI/GL diets promote heart disease in males in the general population.

However, the recent Canadian study in Archives of Internal Medicine found strong evidence linking CHD with high-glycemic index diets.  Although not mentioned in the text of that article, Table 3 on page 664 shows that the association is much stonger in women than in men.  Relative risk for women on a high-glycemic index/load diet was 1.5 (95% confidence interval = 1.29-1.71), and for men the relative risk was 1.06 (95% confidence interval = 0.91-1.20).  See reference below.

Nine of the 37 studies examined the occurrence of type 2 diabetes.  Only one of these studied men only – 42,759 men: the abstract is not available online and the Sydney group does not mention if high-GI or high-GL was positively associated with onset of diabetes in this cohort.  Two of the diabetes studies included both men and women, but the abstracts don’t break down the findings by sex.  [I’m trying to deduce if the major overall findings of this meta-analysis apply to men or not.]

I don’t know anybody willing to change their diet just to avoid the risk of gallstones.  It’s only after they develop symptomatic gallstones that they ask me what they can do about them.  The usual answer is surgery.

The report is well-done and seems free of commercial bias, even though several of the researchers are authors or co-authors of popular books on low-GI eating.

Steve Parker, M.D.

References:

Barclay, Alan W.; Petocz, Peter; McMillan-Price, Joanna; Flood, Victoria M.; Prvan, Tania; Mitchell, Paul; and Brand-Miller, Jennie C.  Glycemic index, glycemic load, and chronic disease risk – a meta-analysis of observational studies [of mostly women].  American Journal of Clinical Nutrition, 87 (2008): 627-637.

Brand-Miller, Jennie, et al.  “The New Glucose Revolution: The Authoritative Guide to the Glycemic Index – The Dietary Solution for Lifelong Health.”  Da Capo Press, 2006.

Mente, Andrew, et al.  A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart DiseaseArchives of Internal Medicine, 169 (2009): 659-669.

4 Comments

Filed under Causes of Diabetes, Glycemic Index and Load

Colesevelam (Welchol) Treatment for Type 2 Diabetes

Are you sick and tired of taking pills?

Are you sick and tired of taking pills?

David Mendosa’s May 20, 2009, blog post at HealthCentral.com brought to my attention a little-used diabetes drug, colesevelam HCl.  The brand name is Welchol, and it has been around in the U.S. since 2000 for treatment of high cholesterol.
Colesevelam is in a class called bile acid sequestrants.  Taken in pill form, it is minimally absorbed from the gastrointestinal tract, which generally minimizes the chance for serious side effects.  It can, however, interfere with absorption of many other drugs, thereby impairing the effectiveness of those drugs. 

The U.S. Food and Drug Administration has approved the drug for 1) treating high cholestrol, and 2) treatment of type 2 diabetes in combination with insulin or oral antidiabetes medications.  So, it’s not a diabetic medication to be used by itself.  The most common side effects are constipation and dyspepsia. 

WebMD has a patient-friendly article on colesevelam.

I see very few patients using Welchol for treatment of diabetes, and I’m not entirely sure why.  It may be related to the interference with absorption of other drugs.  Many people with diabetes are on multiple oral medications.  Another reason is that, since it cannot be used alone, it adds a layer of complexity to treatment.  Some physicians would be tempted to use it in a diabetic with high cholesterol: the old “kill two birds with one stone” trick.  However, it’s unknown whether such use acturally reduces cardiovasular disease and mortality.  Statin drugs – the market leaders in lowering cholesterol – do reduce cardiovascular disease rates and mortality. 

By my count, we how have 10 classes of drugs to help us fight diabetes, compared with three or so when I started my medical career.

Steve Parker, M.D.

Additional information:  FDA Prescribing Information.

Comments Off on Colesevelam (Welchol) Treatment for Type 2 Diabetes

Filed under Drugs for Diabetes

Health on the Net Foundation’s Code of Conduct

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

 

I am pleased to announce that in May of this year the Diabetic Mediterranean Diet Blog met the accreditation criteria of the Health on the Net Foundation’s Code of Conduct for medical and health Web sites.

From the HON website:

The Health On the Net Foundation (HON) promotes and guides the deployment of useful and reliable online health information, and its appropriate and efficient use.  Created in 1995, HON is a non-profit, non-governmental organization, accredited to the Economic and Social Council of the United Nations.  For twelve years, HON has focused on the essential question of the provision of health information to citizens, information that respects ethical standards.  To cope with the unprecedented volume of healthcare information available on the Net, the HONcode of conduct offers a multi-stakeholder consensus on standards to protect citizens from misleading health information.

Here are HONcode criteria I pledge to uphold:

  1. Authoritative.  Any medical or health advice provided and hosted on this site will only be given by medically trained and qualified professionals unless a clear statement is made that a piece of advice offered is from a non-medically qualified individual or organisation.
  2. Complementarity.  The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
  3. Privacy.  Confidentiality of data relating to individual patients and visitors to a medical/health Web site, including their identity, is respected by this Web site. The Web site owners undertake to honour or exceed the legal requirements of medical/health information privacy that apply in the country and state where the Web site and mirror sites are located.
  4. Attribution.  Where appropriate, information contained on this site will be supported by clear references to source data and, where possible, have specific HTML links to that data.  The date when a clinical page was last modified will be clearly displayed (e.g. at the bottom of the page).
  5. Justifiability.  Any claims relating to the benefits/performance of a specific treatment, commercial product or service will be supported by appropriate, balanced evidence in the manner outlined above in Principle 4.
  6. Transparency.  The designers of this Web site will seek to provide information in the clearest possible manner and provide contact addresses for visitors that seek further information or support.  The Webmaster will display his/her E-mail address clearly throughout the Web site.
  7. Financial disclosure.  Support for this Web site will be clearly identified, including the identities of commercial and non-commercial organisations that have contributed funding, services or material for the site.
  8. Advertising policy.  If advertising is a source of funding it will be clearly stated.  A brief description of the advertising policy adopted by the Web site owners will be displayed on the site.  Advertising and other promotional material will be presented to viewers in a manner and context that facilitates differentiation between it and the original material created by the institution operating the site.

If you notice any violations of the code, please contact me via email (see Contact page) or contact the Health on the Net Foundation.

Steve Parker, M.D. 

Comments Off on Health on the Net Foundation’s Code of Conduct

Filed under Uncategorized

Spanish Ketogenic Mediterranean Diet

Altea, Plaça de la EsglésiaEver heard of the Spanish Ketogenic Mediterranean Diet?  It looks like a low-carb quasi-Mediterranean diet.

Researchers with the University of Cordoba in Spain studied 40 subjects eating a low-carb “Mediterranean” diet for 12 weeks.  The results were strikingly positive.

Methodology

A medical weight loss clinic was the source of 40 overweight subjects, 22 males and 19 females, average age 38, average body mass index 36.5, average weight 108.6 kg (239 lb).  These folks were interested in losing weight, and were not paid to participate.

Nine subjects were not included in the final analysis due to poor compliance with the study protocol (3), the diet was too expensive (1), a traumatic car wreck (1), or were simply lost to follow-up (4).  So all the data are pooled from the 31 subjects who completed the study.

Blood from all subjects was drawn just before the study began and again after 12 weeks of the diet.

Study diet:  Low-carbohydrate, high in protein [and probably fat, too], unlimited in calories.  Olive oil was the main source of fat (at least 30 ml daily).  Maximum of 30 grams of carbohydrates daily as green vegetables and salad.  200-400 ml daily of red wine.  The authors write:

Participants were permitted 3 portions (200 g/portion) of vegetables daily: 2 portions of salad vegetables (such as alfalfa sprouts, lettuce, escarole, endive, mushrooms, radicchio, radishes, parsley, peppers, chicory, spinach, cucumber, chard and celery), and 1 portion of low-carbohydrate vegetables (such as broccoli, cauliflower, cabbage, artichoke, eggplant, squash, tomato and onion).  3 portions of salad vegetables were allowed only if the portion of low-carbohydrate vegetables were not consumed.  Salad dressing allowed were: garlic, olive oil, vinegar, lemon juice, salt, herbs and spices.

The minimum 30 ml of olive oil were distributed unless in 10 ml per principal meal (breakfast, lunch and dinner).  Red wine (200–400 ml a day) was distributed in 100–200 ml per lunch and dinner.  The protein block was divided in “fish block” and “no fish block”.  The “fish block” included all the types of fish except larger, longer-living predators (swordfish and shark).  The “no fish block” included meat, fowl, eggs, shellfish and cheese.  Both protein blocks were not mixed in the same day and were consumed individually during its day on the condition that at least 4 days of the week were for the “fish block”.

Trans fats (margarines and their derivatives) and processed meats with added sugar were not allowed.

Vitamin and mineral supplements were given.

Subjects measured their ketosis state every morning with urine ketone strips.

Results (averaged)

  • Body weight fell from 108.6 kg (239 lb) to 94.5 kg (209 lb), or 2.5 pounds per week
  • Body mass index fell from 36.5 to 31.8
  • Systolic blood pressure fell from126 to 109 mmHg
  • Diastolic blood pressure fell from 85 to 75 mmHg
  • Total cholesterol fell from 208 to 187 mg/dl
  • LDL chol fell from 115 to 106 mg/dl
  • HDL chol rose from 50 to 55 mg/dl
  • Fasting glucose dropped from 110 to 93 mg/dl
  • Triglycerides fell from 219 to 114 mg/dl
  • No significant differences in male and female subjects
  • No adverse reactions are mentioned

Researchers’ Conclusions

The SKMD [Spanish Ketogenic Mediterranean Diet] is safe, an effective way of losing weight, promoting non-atherogenic lipid profiles, lowering blood pressure and improving fasting blood glucose levels.  Future research should include a larger sample size, a longer term use and a comparison with other ketogenic diets.

My Comments

The researchers called this diet “Mediterranean” based on olive oil, red wine, fish, and vegetables.

What’s “Not Mediterranean” is the paucity of carbohydrates (including whole grains); lack of yogurt, nuts, and legumes; and the high meat/protein intake.

The emphasis on olive oil, red wine, and fish could make this healthier than other ketogenic diets.

Ketogenic diets are notorious for high drop-out rates compared to other diets.  Most people can follow a ketogenic diet for only two or three months.  But several studies suggest greater short-term weight loss for people who stick with it.  Efficacy and superiority are little different from other diets as measured at one year out.

Many of the metabolic improvements seen here might be duplicated with loss of 30 pounds (13.6 kg) over 12 weeks using any reasonable diet.

Average fasting blood sugars in these subjects was 109 mg/dl.  Although not mentioned by the authors, this is in the prediabetes range.  The diet reduced average fasting blood sugar to 93, which would mean resolution of prediabetes.  Dropping body mass index from 36 to 32 by any method would tend to cure prediabetes.

Elevated blood sugar is one component of the “metabolic syndrome.”  Metabolic syndrome was recently shown to be reversible with a Mediterranean diet supplemented with nuts.

I suspect this would be a good program for an overweight person with uncontrolled type 2 diabetes, too.  But it has never been studied in a diabetic population.  So, who knows for sure?

If you’re thinking about doing something like this, get more information and be sure to get your doctor’s approval first.

Steve Parker, M.D.

Addendum:

On April 6, 2008, I had a delightful conversation with Jimmy Moore, of Livin’ La Vida Low-Carb fame regarding this study.  It struck me that the Spanish Ketogenic Mediterranean Diet is probably higher in protein and lower in fat than many other ketogenic weight-loss diets.  Since fish is emphasized over other animal-derived foods, it’s likely also lower in saturated fat.  [In low-carb diets, carbohydrates are substituted with either fats or proteins.]  I’m also convinced I will eventually have to review the validity of the dogmatic diet-heart hypothesis:  Dietary saturated fat, total fat, and cholesterol contribute to atherosclerosis and associated premature death from heart attacks and strokes.

References and Additional Reading:

Perez-Guisado, J., Munoz-Serrano, A., and Alonso-Moraga, A.  Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight lossNutrition Journal, 2008, 7:30.   doi:10.1186/1475-2891-7-30

Bravata, D.M., et al.  Efficacy and safety of low-carbohydrate diets: a systematic reviewJournal of the American Medical Association, 289 (2003): 1,837-1,850.

Gardner, C.D., et al.  Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trialJournal of the American Medical Association, 297 (2007): 696-677.

Stern, L., et al.  The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trialAnnals of Internal Medicine, 140 (2004): 778-785.

Shai, Iris, et al.  Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat DietNew England Journal of Medicine, 359 (2008): 229-241.

11 Comments

Filed under Carbohydrate, ketogenic diet, Weight Loss

Societal Changes and the Increasing Rates of Type 2 Diabetes

42-16033240I ran across a thought-provoking article published a few months ago at DiabetesHealth online.  It’s a non-scientific exploration of the potential causes of “diabesity,” the combination of obesity and type 2 diabetes.

You’ll get a kick out of this especially if you’re over 40.

Click here to read “50 Reasons Why Diabesity Wasn’t Prevalent 50 Years Ago.”

Steve Parker, M.D.

Comments Off on Societal Changes and the Increasing Rates of Type 2 Diabetes

Filed under Causes of Diabetes, DM Prevalence

Free Online Mediterranean Recipes

MPj04329340000[1]Several of the websites below include comments from people who have tried the recipes, as well as nutritional analysis.

http://www.allrecipes.com            Enter search term “Mediterranean”
http://www.arabicnews.com         See Food and Recipes under “Resources”
http://www.cliffordawright.com
http://www.gourmed.gr                For English, click on the British flag in the upper right corner
http://www.mediterrasian.com
http://www.recipezaar.com           Not a sure thing.  Try searching “Mediterranean”
http://www.videojug.com              Check the Mediterranean subsection under “Food & Drink”

Happy hunting!

Steve Parker, M.D.

1 Comment

Filed under Recipes

High Glycemic Load and Low Grain Fiber Increase Risk of Type 2 Diabetes in Men

Minimally refined grain

Minimally refined grain

A study published in 1997 helped establish the association between glycemic load, dietary fiber, and type 2 diabetes in men.

Methodology

Over 42,000 mostly middle-aged men in the Health Professionals Follow-up Study, without diabetes at baseline, were followed over six years to see if  diet composition was related to onset of type 2 diabetes.  Food intake was determined by a questionnaire.  95% of participants were white.

Results

523 cases of type 2 diabetes developed.  Men with the highest glycemic index eating pattern were 37% more likely to develop diabetes compared to the lowest glycemic index.

Cereal (grain) fiber was inversely related to risk of diabetes.  That is, the higher the intake of grain fiber, the lower the risk of developing diabetes.

The combination of high glycemic load and low cereal fiber yielded the highest rate of diabetes.

Total dietary fiber was not associated with reduced risk of diabetes.

Fiber from fruits and vegetables was not associated with diabetes one way or the other.

As other studies found, total carbohydrate intake was not related to risk of diabetes.

Take-Home Points

These findings may or may not apply to women and non-white ethnic groups.

Grains in a minimally refined form reduced the incidence of diabetes in this population.

Diets with a high glycemic load increase the risk of diabetes, at least in men.

Elsewhere, I’ve reviewed studies indicating that, in women, both high glycemic load and high glycemic index eating increase the risk of type 2 diabetes.  Click here for details.

We must wonder if  established cases of diabetes would respond positively to diets with low glycemic load and grains in a minimally refined form.  Or is it too late?

Steve Parker, M.D.

Reference:  Salmeron, Jorge, et al.  Dietary fiber, glycemic load, and risk of NIDDM in Men.  Diabetes Care, 20 (1997): 545-550

Comments Off on High Glycemic Load and Low Grain Fiber Increase Risk of Type 2 Diabetes in Men

Filed under Carbohydrate, Causes of Diabetes, Fiber, Glycemic Index and Load

Cycloset (Bromocriptine) Approved for Treatment of Type 2 Diabetes

Better living through chemistry

Better living through chemistry

Cycloset (generic name = bromocriptine mesylate) was just approved for treatment of type 2 diabetes by the U.S. Food and Drug Administration.  It’s a completely new approach that increases dopamine activity in the brain.  This review is quite limited—consult your physician or pharmacist for full details.  Remember that drug names vary by country and manufacturer. 

Class

Dopamine receptor agonist.

How Does It Work?

How it lowers glucose levels is not entirely clear, but it may reset or alter glucose metabolism in tissues outside the brain.  Bromocriptine is an ergot derivative that increases dopamine activity in the brain.  Cycloset improves after-meal glucoses without an increase in blood insulin levels.  This is appealing since high insulin levels are implicated as a contributor to some chronic diseases.

Usage

It’s for adults with type 2 diabetes and can be used alone or with certain other diabetes drugs.  “Other drugs” used in clinical trials were mostly metformin and sulfonylureas, with less experience using it with thiazolidinediones.  We know little about using it with insulin.  Bromocriptine is not for type 1 diabetics or diabetic ketoacidosis.  It lowers hemoglobin A1c by 0.6 to 0.9% (absolute decrease).

Dose

Start with 0.8 mg every morning and increase by an additional tablet (0.8 mg) weekly up to 4.8 mg or the maximal tolerated dose (1.6 to 4.8 mg).  Take all of it in the morning.

Side Effects

In clinical studies, the most common cause for discontinuation of the drug was nausea.  It can cause drowsiness, fainting, blood pressure drops with standing (causing lightheadedness, fainting, weakness, or sweating), fatigue, vomiting, and headaches.  Hypoglycemia is not much of a problem, if any, when bromocriptine is used as the sole diabetic medication.  In other words, bromocriptine by itself may slightly increase the risk of hypoglycemia. 

Bromocriptine has been in use for many years to treat other conditions, so we may not see any of the unforeseen consequences that have led to so many drugs being pulled from the market a couple years after FDA approval.

Don’t Use It If You  . . .

-take neuroleptic drugs, are a nursing mother, have syncopal migraines (that make you faint), have hypersensitivity to ergot-related drugs, or have a severe psychotic disorder.

If you gotta have type 2 diabetes, this is a great time in history to have it.  Twenty five years ago, we had maybe three classes of medications to fight it.  By my count, we’re up to 11 classes now.  Always good to have options!

Steve Parker, M.D.

Reference:  VeroScience Announces FDA Approval of Cyclocet for Treatment of  Type 2 Diabetes, in Medical News Today, May 7, 2009.

Cycloset Package Insert

Date last modified: December 2, 2010

Comments Off on Cycloset (Bromocriptine) Approved for Treatment of Type 2 Diabetes

Filed under Drugs for Diabetes

High- vs Low-Protein Weight-Loss Diet in Type 2 Diabetes

 

Mucho protein, amigo

Mucho protein, amigo

A high-protein weight-loss diet yielded greater reduction in LDL cholesterol in both sexes, and greater loss of abdominal fat in overweight type 2 diabetics, compared to a lower-protein diet.  Lower LDL cholesterol levels are associated with lower risk of heart attack.

This scientific study caught my eye because it utilized a high-monounsaturated fat diet for weight loss.  The Mediterranean diet is rich in monounsaturated fats, mostly from olive oil.

Researchers in Australia ran a study to determine the effect of high- versus lower-protein wieght loss diets on fat and lean tissue, glucose levels, and blood lipids.  For perspective, remember that a typical American diet has about 15% of calories from protein, 30% from fat, and 55% from carbohydrates.

Methodology

This was their high-protein diet:  28% protein, 42% CHO, 28% fat (8% saturated fatty acids, 12% monounsaturated fatty acids, 5% polyunsaturated fatty acids).

The low-protein diet:  16% protein, 55% CHO, 26% fat (8% saturated fatty acids, 11% monounsaturated fatty acids, 5% polyunsaturated fatty acids).

They studied 54 obese men (19) and women (35) with type 2 diabetes during 8 weeks of energy restriction (1,600 kcal) and 4 weeks of energy balance.  Body composition was determined by dual-energy X-ray absorptiometry at weeks 0 and 12.

Results

Average weight loss for both groups was 5 kg.  However, women on the HP diet lost significantly more total (5.3 vs 2.8 kg) and abdominal (1.3 vs 0.7 kg) fat compared with the women on the LP diet, whereas, in men, there was no difference in fat loss between diets (3.9 vs 5.1 kg).  Total lean mass decreased in all subjects independently of diet composition.  LDL cholesterol reduction was significantly greater on the HP diet (5.7%) than on the LP diet (2.7%).  Blood glucose levels were reduced 5 or 10% by both diet interventions.  Trigylcerides dropped 20% in both groups.  Insulin concentrations were reduced in both groups.  Subjects lose 2.1% lean mass overall, with no difference between the groups.

Conclusions of the Study Authors

Both dietary patterns resulted in improvements in the cardiovascular disease (CVD) risk profile as a consequence of weight loss. However, the greater reductions in total and abdominal fat mass in women and greater LDL cholesterol reduction observed in both sexes on the HP diet suggest that it is a valid diet choice for reducing CVD risk in type 2 diabetes.

Take-Home Points

This was a relatively small study, so results may not be widely applicable.

Substituting proteins for carbs doesn’t seem to be detrimental to people with type 2 diabetes needing to lose weight, and may be advantageous:  greater total and abdominal fat loss in women, greater reductions in LDL cholesterol for both sexes.   At least in the short run.

Nephrologists will be concerned that the higher-protein diet, if sustained long-term, could lead to kidney damage.

Current dogma is that the lower-carb (high-protein) dieters should have had lower blood glucose, triglycerides, and HgbA1c levels:  not seen here.

Calorie-restricted diets tend to lower glucose levels and improve lipids, despite diet composition.

Reference:  Parker, Barbara et al.  Effect of a High-Protein, High–Monounsaturated Fat Weight Loss Diet on Glycemic Control and Lipid Levels in Type 2 Diabetes.  Diabetes Care,  25 (2002): 425-430.    From CSIRO Health Sciences and Nutrition, Adelaide, Australia.

1 Comment

Filed under Carbohydrate, Protein, Weight Loss

May is “Mediterranean Month”

42-15584214Oldways and the Mediterranean Foods Alliance announce that May is Mediterranean Month.  It’s a way to promote healthy Mediterranean-style eating.

I can’t think of any other organization that’s done more than Oldways to spread the gospel about the Mediterranean diet.

In this context, “diet” refers to a habitual way of eating rather than a weight-loss program.

But who is Mediterranean Foods Alliance?  From their website, MFA “is a group of devoted partners (health professionals, scientists, food companies, retailers, culinary experts, and media) working together to help people eat better with the Mediterranean Diet.”

Mediterranean Month features include:

* Mediterranean diet recipe contest (with prizes!)
* 7-day Mediterranean diet meal plan
* budget-friendly recipes
* Mediterranean Month Calendar Tips for incorporating the Mediterranean diet into your life

Click on the links in the first paragraph for details.

Steve Parker, M.D.

1 Comment

Filed under Mediterranean Diet